Alerts will be sent to your verified email
Verify EmailBACPHAR
Bacil Pharma
|
Vista Pharma
|
Shelter Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-73.86 % | -9.45 % | 15.08 % |
5yr average Equity Multiplier
|
1.72 | 1.52 | 1.38 |
5yr Average Asset Turnover Ratio
|
0.0 | 0.14 | 2.02 |
5yr Avg Net Profit Margin
|
0.0 | -199.64 % | 7.29 % |
Price to Book
|
2.16 | 1.28 | 0.0 |
P/E
|
49.32 | 0.0 | 6.87 |
5yr Avg Cash Conversion Cycle
|
0.0 | 397.29 Days | 151.86 Days |
Inventory Days
|
0.0 | 3019.63 Days | 65.6 Days |
Days Receivable
|
0.0 | 452.93 Days | 77.72 Days |
Days Payable
|
23.71 Days | 1804.78 Days | 5.04 Days |
5yr Average Interest Coverage Ratio
|
-950.16 | -2.3 | 71.95 |
5yr Avg ROCE
|
-81.01 % | -7.56 % | 21.3 % |
5yr Avg Operating Profit Margin
|
0.0 | -188.68 % | 11.0 % |
5 yr average Debt to Equity
|
0.08 | 0.33 | 0.04 |
5yr CAGR Net Profit
|
-28.45 % | 4.15 % | 138.7 % |
5yr Average Return on Assets
|
-72.13 % | -6.28 % | 11.22 % |
Shareholdings
|
|||
Promoter Holding
|
0.2 % | 21.19 % | 52.32 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-42.47 % | -14.25 % | -4.57 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.02 % | 0.0 |
Bacil Pharma
|
Vista Pharma
|
Shelter Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|